Targeting Toll-like receptors: emerging therapeutics?

By E. J. Hennessy, A. Parker, Luke A. O'Neill. Nature reviews. Drug discovery, 2010

853 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology, Microbiology

View Paper: https://www.semanticscholar.org/paper/f4ab99c0e5da679e5e0781c38613099f54831328

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Forbes
2. M. Cooper

Citations in the corpus

• Mechanisms of diabetic complications. (2013, background): “Toll-like receptors (TLRs) are a family of pattern recognition receptors with a diverse number of ligands including LPS, HMGB1, and fragmented DNA from necrotic cells, which play a role in both innate and adaptive immunity (239).”